HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
128,322,139
Share change
+495,786
Total reported value
$5,647,663,757
Put/Call ratio
34%
Price per share
$44.00
Number of holders
359
Value change
+$24,849,414
Number of buys
203
Number of sells
131

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2022

As of 30 Jun 2022, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 359 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 128,322,139 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, STATE STREET CORP, Invesco Ltd., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, JPMORGAN CHASE & CO, MACQUARIE GROUP LTD, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 360 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
298
Q2 2022 holders
359
Holder diff
61
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.